We are actively seeking opportunities to acquire individual products, portfolios of products or corporates and have established a strong contact network within the industry to facilitate this.
Over the past 16 years, we have completed a total of 28 acquisitions, acquiring products from several of the multi-national and mid-tier pharma companies, as well as making a number of corporate acquisitions.
We also welcome speculative approaches and are open to considering acquisitions in any therapy area or geography, although we are particularly interested in products which complement any of our existing therapy areas or which have sales originating in the ‘EU5’ territories (UK, France, Germany, Spain & Italy) or in China.
Our evaluation processes are well developed and managed by a dedicated team of professionals who engage with colleagues in both the commercial and functional support areas (technical operations, medical, regulatory, finance, legal) as required in order to facilitate a rapid and thorough assessment. As part of this process, the team routinely manage integration planning and any transitional arrangements, so as to make the subsequent transition as smooth as possible.
If you have an opportunity you’d like to discuss with us, please get in touch: firstname.lastname@example.org or call our switchboard on +44 (0) 1249 466966.
You May Also Be Interested In